Korean Drug (Korea) Buy Hold or Sell Recommendation
| 014570 Stock | KRW 6,590 10.00 0.15% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Korean Drug Co is 'Hold'. Macroaxis provides Korean Drug buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 014570 positions. The advice algorithm takes into account all of Korean Drug's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Korean Drug's buy or sell advice are summarized below:
Real Value 4.7 K | Hype Value 6.6 K | Market Value 6.6 K | Naive Value 6.6 K |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Korean Drug Co given historical horizon and risk tolerance towards Korean Drug. When Macroaxis issues a 'buy' or 'sell' recommendation for Korean Drug Co, the advice is generated through an automated system that utilizes algorithms and statistical models.
Korean |
Execute Korean Drug Buy or Sell Advice
The Korean recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Korean Drug Co. Macroaxis does not own or have any residual interests in Korean Drug Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Korean Drug's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Ignores market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Korean Drug Trading Alerts and Improvement Suggestions
| Korean Drug generated a negative expected return over the last 90 days | |
| About 50.0% of the company shares are owned by insiders or employees |
Korean Drug Returns Distribution Density
The distribution of Korean Drug's historical returns is an attempt to chart the uncertainty of Korean Drug's future price movements. The chart of the probability distribution of Korean Drug daily returns describes the distribution of returns around its average expected value. We use Korean Drug Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Korean Drug returns is essential to provide solid investment advice for Korean Drug.
| Mean Return | -0.04 | Value At Risk | -2.2 | Potential Upside | 2.63 | Standard Deviation | 1.42 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Korean Drug historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Korean Drug Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Korean Drug or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Korean Drug's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Korean stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.00 | |
β | Beta against NYSE Composite | 0.00 | |
σ | Overall volatility | 1.37 | |
Ir | Information ratio | -0.1 |
Korean Drug Volatility Alert
Korean Drug Co exhibits very low volatility with skewness of 0.3 and kurtosis of 0.65. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Korean Drug's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Korean Drug's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Korean Drug Fundamentals Vs Peers
Comparing Korean Drug's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Korean Drug's direct or indirect competition across all of the common fundamentals between Korean Drug and the related equities. This way, we can detect undervalued stocks with similar characteristics as Korean Drug or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Korean Drug's fundamental indicators could also be used in its relative valuation, which is a method of valuing Korean Drug by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Korean Drug to competition |
| Fundamentals | Korean Drug | Peer Average |
| Return On Equity | 15.3 | -0.31 |
| Return On Asset | 0.0702 | -0.14 |
| Profit Margin | 0.11 % | (1.27) % |
| Operating Margin | 0.14 % | (5.51) % |
| Current Valuation | 94.01 B | 16.62 B |
| Shares Outstanding | 11 M | 571.82 M |
| Shares Owned By Insiders | 50.19 % | 10.09 % |
| Shares Owned By Institutions | 0.28 % | 39.21 % |
| Price To Earning | 55.67 X | 28.72 X |
| Price To Sales | 1.11 X | 11.42 X |
| Revenue | 74.47 B | 9.43 B |
| Gross Profit | 28.69 B | 27.38 B |
| EBITDA | 11.14 B | 3.9 B |
| Net Income | 9.04 B | 570.98 M |
| Cash And Equivalents | 4.68 B | 2.7 B |
| Cash Per Share | 980.50 X | 5.01 X |
| Total Debt | 15 M | 5.32 B |
| Debt To Equity | 0.10 % | 48.70 % |
| Current Ratio | 6.69 X | 2.16 X |
| Cash Flow From Operations | 8.81 B | 971.22 M |
| Number Of Employees | 14 | 18.84 K |
| Beta | 0.25 | -0.15 |
| Market Capitalization | 84.81 B | 19.03 B |
| Total Asset | 88.61 B | 29.47 B |
| Retained Earnings | 40.74 B | 9.33 B |
| Working Capital | 33.63 B | 1.48 B |
| Current Asset | 40.97 B | 9.34 B |
| Current Liabilities | 7.34 B | 7.9 B |
| Annual Yield | 0.01 % | |
| Net Asset | 88.61 B |
Korean Drug Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Korean . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0253 | |||
| Daily Balance Of Power | 0.0588 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 6645.0 | |||
| Day Typical Price | 6626.67 | |||
| Market Facilitation Index | 170.0 | |||
| Price Action Indicator | (50.00) | |||
| Period Momentum Indicator | 10.0 | |||
| Relative Strength Index | 83.96 |
About Korean Drug Buy or Sell Advice
When is the right time to buy or sell Korean Drug Co? Buying financial instruments such as Korean Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Korean Drug in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Retail Thematic Idea Now
Retail
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Retail theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Retail Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Korean Drug Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Korean Drug information on this page should be used as a complementary analysis to other Korean Drug's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Korean Stock analysis
When running Korean Drug's price analysis, check to measure Korean Drug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Korean Drug is operating at the current time. Most of Korean Drug's value examination focuses on studying past and present price action to predict the probability of Korean Drug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Korean Drug's price. Additionally, you may evaluate how the addition of Korean Drug to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |